| | | | | | | |
 | GILEAD SCIENCES, INC. | -0.83% | 2.83% | -11.21% | -2.83% | -3.62% | 81 543 |
| REGENERON PHARMACEUTICALS, INC. | -1.08% | 4.81% | 8.22% | 37.47% | 118.66% | 74 440 |
| VERTEX PHARMACEUTICALS | -0.44% | 7.33% | 22.79% | 30.39% | 56.98% | 69 269 |
 | WUXI APPTEC CO., LTD. | -3.54% | -10.58% | -25.70% | -36.93% | 159.96% | 39 423 |
| BIONTECH SE | 2.25% | -1.52% | -38.65% | -21.85% | --.--% | 37 588 |
 | GENMAB A/S | -0.61% | -0.71% | -19.73% | -13.16% | 72.54% | 19 850 |
 | ARGENX SE | -0.03% | 0.31% | -6.85% | 30.71% | 142.13% | 17 140 |
| BEIGENE, LTD. | 3.02% | -2.81% | -51.55% | -62.15% | 3.67% | 13 146 |
| NEUROCRINE BIOSCIENCES, INC. | 1.65% | 4.04% | 5.48% | -6.72% | 12.45% | 8 447 |
| HALOZYME THERAPEUTICS, INC. | 0.67% | 0.81% | 15.89% | 10.95% | 202.40% | 6 378 |
| LEGEND BIOTECH CORPORATION | 0.49% | -3.74% | -15.58% | 4.82% | --.--% | 6 040 |
| SAREPTA THERAPEUTICS, INC. | 3.52% | 0.03% | -21.27% | -5.40% | -41.33% | 5 993 |
| EXELIXIS, INC. | 2.13% | -8.62% | -0.49% | -18.79% | -10.66% | 5 712 |
| INTRA-CELLULAR THERAPIES, INC. | 3.62% | -3.13% | 12.19% | 49.53% | 335.93% | 5 345 |
| ASCENDIS PHARMA A/S | -1.75% | 5.00% | -34.05% | -33.68% | -31.20% | 5 039 |
| | | | | | | |
| | Media | 0.60% | -0.40% | -10.70% | -2.51% | 78.30% | |
| | Media ponderata per Capi. | -0.36% | 1.40% | -6.47% | 4.63% | 72.33% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
